| 0 (0%) | 11-30 07:29 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 32.02 |
1-year : | 37.4 |
| Resists | First : | 27.42 |
Second : | 32.02 |
| Pivot price | 26.82 |
|||
| Supports | First : | 26.63 |
Second : | 26.15 |
| MAs | MA(5) : | 26.56 |
MA(20) : | 26.84 |
| MA(100) : | 26.59 |
MA(250) : | 26.05 |
|
| MACD | MACD : | -0.1 |
Signal : | -0.1  |
| %K %D | K(14,3) : | 39.4 |
D(3) : | 28.6 |
| RSI | RSI(14): 53.6 |
|||
| 52-week | High : | 27.62 | Low : | 23.11 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ COMT ] has closed below upper band by 37.8%. Bollinger Bands are 19.6% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 26.7 - 26.89 | 26.89 - 27.03 |
| Low: | 26.02 - 26.23 | 26.23 - 26.38 |
| Close: | 26.39 - 26.7 | 26.7 - 26.94 |
Thu, 27 Nov 2025
Technical Reactions to COMT Trends in Macro Strategies - news.stocktradersdaily.com
Mon, 01 Sep 2025
The good stress guide - Financial Times
Sat, 26 Jul 2025
Empagliflozin reduces liver fibrosis by restoring catechol- O -methyltransferase activity associated with magnesium levels - Nature
Thu, 29 May 2025
Joe Malizia, PT, DPT, OCS, COMT, CSCS - HSS | Hospital for Special Surgery
Thu, 29 May 2025
Vincent J. Luppino, PT, DPT, OCS, Cert. DN, COMT, CSCS - HSS | Hospital for Special Surgery
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 0 (M) |
| Shares Float | 0 (M) |
| Held by Insiders | 0 (%) |
| Held by Institutions | 0 (%) |
| Shares Short | 0 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | 0 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | 0 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | 0 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | 0 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | 0 |
| Price to Cash Flow | 0 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|